Announcement on the evening of July 29th | WuXi AppTec, SINOMED, UBTECH ROBOTICS release semi-annual reports; Aier Ophthalmology acquires equity of 35 hospitals; China Fortune Land Development enters the low-altitude economy

Performance Changes

A-share Market:

WuXi AppTec: In the first half of the year, the operating income was RMB 17.241 billion, a year-on-year decrease of 8.64%; the net profit attributable to shareholders of the listed company was RMB 4.24 billion, a year-on-year decrease of 20.20%. It is expected that the revenue in 2024 will reach RMB 38.3-40.5 billion. Excluding specific commercial production projects, it will maintain positive growth with an expected growth rate of 2.7%-8.6%.

SINOMED: It is expected to achieve operating income of RMB 214 million in the first half of the year, a year-on-year increase of 32.49%; the net profit attributable to shareholders of the listed company is RMB 7.66 million, turning losses into profits with a growth of 125.88% year-on-year. The performance improvement is mainly due to a 70.77% year-on-year increase in revenue from coronary intervention business, among others.

Fuyao Glass: Achieved operating income of RMB 18.34 billion in the first half of the year, a year-on-year increase of 22.01%; net profit attributable to shareholders of the listed company was RMB 3.499 billion, a year-on-year increase of 23.35%; basic earnings per share were RMB 1.34.

QuantumCTek: Achieved a year-on-year revenue growth of 22.44% in the first half of the year, with outstanding performance in quantum computing and quantum precision measurement businesses, achieving year-on-year growth of 89.92% and 215.51% respectively.

Houpu Holding: The operating income in the first half of the year was RMB 198 million, a year-on-year decrease of 53.71%; the net profit attributable to shareholders of the listed company was -RMB 20.0191 million, a year-on-year decrease of 424.55%.

Sujiao Technology: Achieved operating income of RMB 2.059 billion in the first half of the year, a year-on-year increase of 2.62%; net profit was RMB 158 million, a year-on-year decrease of 7.75%. Despite revenue growth, the decrease in net profit reflects the challenges the company faces in the current macroeconomic environment.

Hong Kong Stock Market:

UBTECH ROBOTICS: Expected revenue in the first half of the year is around RMB 450 million to 500 million, a year-on-year growth of 72% to 91%. The revenue growth is mainly due to increased sales of the company's robot products and new product launches.

China Railway: In the second quarter, according to business type statistics, the new contract amount for design consulting was RMB 6.92 billion, a year-on-year decrease of 7.1%; the new contract amount for engineering construction was RMB 310.1 billion, a year-on-year decrease of 16.0%.

Equity Transfer, Repurchase, Increase Holdings

Chunqiu Electronic: Intends to transfer 65% equity of its holding subsidiary Nanchang Chunqiu Electronic Technology Co., Ltd. to Shanghai Moqin Intelligent Technology Co., Ltd. for RMB 348 million.

Zuoli Pharmaceutical: Plans to repurchase up to 15 million shares for equity incentives.

Hemai Group: Plans to use RMB 100 million to RMB 200 million of the proceeds from the initial public offering for share repurchases, for employee shareholding plans or equity incentives, with a repurchase price not exceeding RMB 185 per share.

Teyi Pharmaceutical: As of today, the company has repurchased 11,514,584 shares through the Shenzhen Stock Exchange trading system by centralized bidding trading, accounting for 2.25% of the company's current total share capital Xiamen Xiangyu: Director Zhang Shuili increased his holdings by 30,400 shares through the Shanghai Stock Exchange's centralized bidding trading system, with an average price of 5.21 yuan per share.

Hualing Steel: Controlling shareholders and concerted actors plan to continue increasing their holdings by 0.5%-1%.

Investment Cooperation, Project Bidding, Business Changes

Oriental Materials: The company's controlling shareholder and actual controller, Mr. Xu Guangbin, is not missing and is performing his duties normally. The company's business operations are normal, and there are no undisclosed matters that should be disclosed.

CR Sanjiu: Signed a "Strategic Cooperation Agreement" with the Shenzhen Branch of the China Development Bank. The agreement is valid for 5 years, with an intended cooperation amount of 10 billion yuan in various financial products.

Huaxia Happiness: Signed a "Strategic Cooperation Agreement" with Langfang Linkong Investment Development Co., Ltd., planning to carry out long-term cooperation in the low-altitude economy field, establish a strategic partnership, and jointly promote the development of the low-altitude economy industry.

Donghong Shares: Won the bid for the Yantai Port LNG Long-distance Pipeline Project, with a value exceeding 341 million yuan.

Longquan Shares: Wholly-owned subsidiary Xinfeng Pipe Industry won the bid for a China General Nuclear Power Corporation project, with a bid price of 58.7916 million yuan.

ZhiFei Biological: The quadrivalent influenza virus split vaccine (ZFA02 adjuvant) developed by the wholly-owned subsidiary ZhiFei Longke Ma has received a notice of acceptance of the drug clinical trial application from the National Medical Products Administration.

M&A, Restructuring, Private Placement

Aier Eye Hospital: Plans to acquire partial equity of 35 hospitals for 898 million yuan.

Zhongci Electronics: Plans to acquire 5.3971% equity of Beijing Guolian Wanzhong Semiconductor Technology Co., Ltd. held by Beijing Guolian Zhixin Enterprise Management Center in cash, with a transaction price of 25.734744 million yuan. After the transaction is completed, Guolian Wanzhong will become a wholly-owned subsidiary of the company.

Gree Real Estate: The adjustment of the restructuring plan has received preliminary approval from the Zhuhai State-owned Assets Supervision and Administration Commission. The specific details of the restructuring plan are still under discussion, aiming to complete the restructuring with high quality and efficiency.

Yida Shares: Plans to raise no more than 244 million yuan through private placement, for the technological transformation project of producing 220,000 tons of epoxy propane (ethylene) derivative products annually